Latest News

Thursday, July 20, 2017 | Retina, Spark Therapeutics

Spark Therapeutics Receives Rare Pediatric Disease Designation for Investigational Luxturna (Voretigene Neparvovec) from FDA

Spark Therapeutics announced that the Offices of Orphan Products Development and Pediatric Therapeutics of the FDA have designated investigational Luxturna (voretigene neparvovec) as a drug …

Read the full story

Thursday, July 20, 2017 | Earnings & Financials, Kala Pharmaceuticals

Kala Pharmaceuticals Announces Pricing of Initial Public Offering

Kala Pharmaceuticals announced that is has priced its initial public offering of 6,000,000 shares of its common stock at a public offering price of $15 per share, for aggregate gross proceeds of appro…

Read the full story

Thursday, July 20, 2017 | Acquisitions/Mergers

Quidel Announces Definitive Agreement to Acquire Alere Triage Assets

Quidel, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that it has entered into definitive agreements to acquire the…

Read the full story

Wednesday, July 19, 2017 | Clinical Trials, Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Reports Positive Roclatan Phase 3, 12-Month Topline Safety Results

Aerie Pharmaceuticals reported the successful 12-month safety results of the company’s “Mercury 1” phase 3 registration trial for its fixed-dose combination product candidate, Roclat…

Read the full story

Wednesday, July 19, 2017 | Product Releases

Google Glass is Back, With a New Vision

Google is taking another stab at reviving one of its most high-profile flops. Five years ago, Google unveiled Google Glass, a futuristic gadget with the promise of changing how consumers take pictures…

Read the full story

Wednesday, July 19, 2017 | Clinical Trials, AMD, BioTime

Data From BioTime’s Phase 1/2a OpRegen Trial to be Presented at the 2017 AAO Annual Meeting

BioTime announced that an abstract related to the company’s retinal tissue implant has been accepted for a paper presentation at the American Academy of Ophthalmology (AAO) annual meeting being …

Read the full story

Tuesday, July 18, 2017 | Product Releases

Eyefficient Adds MediWorks Portable Fundus Camera to Line of Equipment

Eyefficient is partnering with MediWorks to introduce their new hand-held fundus camera, the FC160, in the United States. The FC160 joins Eyefficient’s other MediWorks equipment, including Digit…

Read the full story

Tuesday, July 18, 2017 | Earnings & Financials, Alcon

Latest Novartis Earnings Show Signs of a Rebound at Alcon

As part of its second quarter earnings, Novartis reported that sales at its Alcon unit accelerated in the second quarter. Novartis Chief Executive Joe Jimenez said the results increase the number of o…

Read the full story

Tuesday, July 18, 2017 | Management/Leadership, IRIDEX

Iridex Announces Appointment Of Ann Rhoads To Its Board Of Directors

Iridex Corporation announced the appointment of Ann Rhoads to the company's board of directors, Audit Committee, and Compensation Committee, effective immediately. "We are delighted to add…

Read the full story

Tuesday, July 18, 2017 | Management/Leadership, Avedro

Donald J. Zurbay Joins Avedro’s Board of Directors

Avedro announced that Donald J. Zurbay has been elected to its board of directors. A veteran finance executive with more than 27 years in financial operations and accounting, Mr. Zurbay is the former …

Read the full story

Monday, July 17, 2017 | Conferences

SMi Group Announces the Launch of the Ophthalmic Drugs Conference

SMi Group has announced the launch of the Ophthalmic Drugs Conference, being held on the November 28-29, 2017, at the Copthorne Tara Hotel in London. Ocular disease therapy has seen a surge in inno…

Read the full story

Monday, July 17, 2017 | Clinical Trials, Spark Therapeutics

Spark Therapeutics’ Biologics License Application for Investigational Voretigene Neparvovec Accepted for Filing by FDA

Spark Therapeutics announced that the FDA has accepted for filing the biologics license application (BLA) and granted priority review for voretigene neparvovec, an investigational, potential one-time …

Read the full story

Monday, July 17, 2017 |

British Surgeons Find 27 Contact Lenses Lodged in Woman’s Eye

British surgeons were prepping a 67-year-old woman for cataract surgery when a trainee ophthalmologist found a “blueish mass” in one eye. The mass was causing the patient discomfort, which…

Read the full story

Monday, July 17, 2017 | Medical Studies

India Ophthalmic Market Forecast to Reach $1.8 Billion by 2022

Market Scope forecasts that India’s $1.3 billion ophthalmic market will grow at a compound annual growth rate (CAGR) of 6.8% a year to $1.8 billion by 2022. India is the fastest growing econo…

Read the full story

Monday, July 17, 2017 | Medical Studies

RightEye Clinical Case Study Highlights Risk of Long-Term Binocular Vision Issues Following Concussions

RightEye announced the publication of a new clinical case study published in the journal Translational Biomedicine demonstrating the long-term eye movement issues that can affect patients with concuss…

Read the full story
Load More